Pandey, Ambarish <br/><br/>
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.  [electronic resource] 

 -  Circulation  12 2019 
 - 2076-2088 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.119.043337  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>American Heart Association<br/>Antihypertensive Agents--therapeutic use<br/>Biomarkers--blood<br/>Cardiology--standards<br/>Cohort Studies<br/>Female<br/>Humans<br/>Hypertension--blood<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Practice Guidelines as Topic--standards<br/>Prospective Studies<br/>Risk Assessment<br/>Troponin T--blood<br/>United States--epidemiology